Literature DB >> 28838671

Biochemical Characterization of Prions.

Michele Fiorini1, Matilde Bongianni2, Salvatore Monaco2, Gianluigi Zanusso2.   

Abstract

Prion disease or transmissible spongiform encephalopathies are characterized by the presence of the abnormal form of the prion protein (PrPSc). The pathological and transmissible properties of PrPSc are enciphered in its secondary and tertiary structures. Since it's well established that different strains of prions are linked to different conformations of PrPSc, biochemical characterization of prions seems a preliminary but reliable approach to detect, analyze, and compare prion strains. Experimental biochemical procedures might be helpful in distinguishing PrPSc physicochemical properties and include resistance to proteinase K (PK) digestion, insolubility in nonionic detergents, PK-resistance under denaturing conditions and sedimentation properties in sucrose gradients. This biochemical approach has been extensively applied in human prion disorders and subsequently expanded for PrPSc characterization in animals. In particular, in sporadic Creutzfedlt-Jakob disease (sCJD) PrPSc is characterized by two main glycotypes conventionally named Type 1 and Type 2, based on the apparent gel migration at 21 and 19kDa of the PrPSc PK-resistant fragment. An additional PrPSc type was identified in sCJD characterized by an unglycosylated dominant glycoform pattern and in 2010 a variably protease-sensitive prionopathy (VPSPr) was reported showing a PrPSc with an electrophoretic ladder like pattern. Additionally, the presence of PrPSc truncated fragments completes the electrophoretic characterization of different prion strains. By two-dimensional (2D) electrophoretic analysis additional PrPSc pattern was identified, since this procedure provides information about the isoelectric point and the different peptides length related to PK cleavage, as well as to glycosylation extent or GPI anchor presence. We here provide and extensive review on PrPSc biochemical analysis in human and animal prion disorders. Further, we show that PrPSc glycotypes observed in CJD share similarities with PrPSc in bovine spongiform encephalopathy forms (BSE).
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biochemical phenotype; Conformational assays; Pathological prion protein; Prion disorders; Prion protein; Protease resistant-PrP; Transmissible spongiform encephalopathies; Two-dimensional analysis

Mesh:

Substances:

Year:  2017        PMID: 28838671     DOI: 10.1016/bs.pmbts.2017.06.012

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  4 in total

1.  Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.

Authors:  Yuta Takaichi; James K Chambers; Hiroyuki Inoue; Yasuhisa Ano; Akihiko Takashima; Hiroyuki Nakayama; Kazuyuki Uchida
Journal:  Acta Neuropathol Commun       Date:  2020-06-19       Impact factor: 7.801

2.  Comparison of conventional, amplification and bio-assay detection methods for a chronic wasting disease inoculum pool.

Authors:  Erin McNulty; Amy V Nalls; Samuel Mellentine; Erin Hughes; Laura Pulscher; Edward A Hoover; Candace K Mathiason
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

3.  Inactivation of Prions by Low-Temperature Sterilization Technology Using Vaporized Gas Derived from a Hydrogen Peroxide-Peracetic Acid Mixture.

Authors:  Akikazu Sakudo; Daiki Anraku; Tomomasa Itarashiki
Journal:  Pathogens       Date:  2020-12-31

Review 4.  Neurodegenerative Proteinopathies in the Proteoform Spectrum-Tools and Challenges.

Authors:  Aneeqa Noor; Saima Zafar; Inga Zerr
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.